ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 117 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,388,000 | -30.0% | 100,000 | -56.3% | 1.48% | -15.6% |
| Q3 2017 | $4,843,000 | +154.6% | 228,837 | +110.3% | 1.75% | +139.1% |
| Q2 2017 | $1,902,000 | -5.2% | 108,837 | -5.2% | 0.73% | -3.6% |
| Q1 2017 | $2,006,000 | -18.1% | 114,765 | -20.7% | 0.76% | -44.9% |
| Q4 2016 | $2,448,000 | +30.0% | 144,765 | +26.1% | 1.38% | +21.6% |
| Q3 2016 | $1,883,000 | +8.4% | 114,765 | 0.0% | 1.13% | -19.0% |
| Q2 2016 | $1,737,000 | +119.3% | 114,765 | +109.6% | 1.40% | +433.6% |
| Q1 2016 | $792,000 | +89.5% | 54,765 | +270.9% | 0.26% | +15.9% |
| Q4 2015 | $418,000 | -16.7% | 14,765 | -50.8% | 0.23% | -3.8% |
| Q3 2015 | $502,000 | – | 30,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |